sameAs
Comparison of DNA extraction methods for microbial community profiling with an application to pediatric bronchoalveolar lavage samplesA comparison of two informative SNP-based strategies for typing Pseudomonas aeruginosa isolates from patients with cystic fibrosisIvacaftor for patients with cystic fibrosisBronchoscopy-guided antimicrobial therapy for cystic fibrosisNebulised hypertonic saline solution for acute bronchiolitis in infantsBronchoscopy-guided antimicrobial therapy for cystic fibrosisNebulized hypertonic saline solution for acute bronchiolitis in infantsNebulized hypertonic saline solution for acute bronchiolitis in childrenYear in review 2015: Interstitial lung disease, pulmonary vascular disease, pulmonary function, sleep and ventilation, cystic fibrosis and paediatric lung diseaseA Novel Method and Its Application to Measuring Pathogen Decay in Bioaerosols from Patients with Respiratory DiseaseGenotypic Diversity within a Single Pseudomonas aeruginosa Strain Commonly Shared by Australian Patients with Cystic FibrosisNew treatments targeting the basic defects in cystic fibrosis.Genetic modifiers of liver disease in cystic fibrosis.Realising opportunities for evidence-based cancer service delivery and research: linking cancer registry and administrative data in Australia.Novel neutrophil-derived proteins in bronchoalveolar lavage fluid indicate an exaggerated inflammatory response in pediatric cystic fibrosis patients.Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection.Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis.Effect of temperature on cystic fibrosis lung disease and infections: a replicated cohort study.Year in review 2013: Lung cancer, respiratory infections, tuberculosis, cystic fibrosis, pleural diseases, bronchoscopic intervention and imagingBacterial causes of empyema in children, Australia, 2007-2009.Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age.Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation.Factors influencing acquisition of Burkholderia cepacia complex organisms in patients with cystic fibrosis.Controlled longitudinal study of bone mass accrual in children and adolescents with cystic fibrosis.Nebulized Hypertonic Saline for Acute Bronchiolitis: A Systematic Review.High-throughput single-nucleotide polymorphism-based typing of shared Pseudomonas aeruginosa strains in cystic fibrosis patients using the Sequenom iPLEX platform.Low rates of Pseudomonas aeruginosa misidentification in isolates from cystic fibrosis patients.Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis.Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study.A CFTR potentiator in patients with cystic fibrosis and the G551D mutation.Phenotypic characterization of clonal and nonclonal Pseudomonas aeruginosa strains isolated from lungs of adults with cystic fibrosis.A d-optimal designed population pharmacokinetic study of oral itraconazole in adult cystic fibrosis patients.Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.Disease surveillance using bronchoalveolar lavage.The long term efficacy of gastrostomy feeding in children with cystic fibrosis on anthropometric markers of nutritonal status and pulmonary function.Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium.Acute viral bronchiolitis in children- a very common condition with few therapeutic options.Year-in-review 2010: asthma, COPD, cystic fibrosis and airway biology.What does advanced practice mean to Australian paediatric pharmacists? A focus group study.Characteristics of adverse medication events in a children's hospital.
P50
Q21134698-8C2FFC66-1C2E-44B4-903C-FAB989E6EB4BQ21261806-EDEB3F76-6F75-4A36-B859-0584E958DAC5Q22305938-5A6F0564-C55A-44E2-A7D2-E50FE2E3970EQ24186413-B877D365-BE74-48E0-AC0A-07E5F6FC5233Q24200958-00D6A9B0-7FF1-430A-855E-308882A2FB58Q24201620-1CC178BB-4F83-4E75-8EB7-B0CA7A8609A2Q24241332-8D4481E8-5E5F-4E57-9F9E-505675EE3A7AQ24246001-A1445E8E-7CCE-45CA-A3E5-4777A8BB76F4Q26766313-3856D193-0A3A-4A43-94C1-BB827F6465BAQ28383536-88768105-A3E4-40D5-B9DE-5B9953AAFED2Q28551306-CA8A885D-0686-4622-8F1E-4F3CB83FA5CBQ30402508-A7D02FCB-9CFB-49F1-A26B-FAF9BAC01BB9Q30418279-EF939F9B-AEA7-412A-B931-5FB933FE921BQ30854442-A4F0944B-4CC1-4B38-AA34-DD28E525B056Q33294331-E757D6CB-A45E-4BFE-B2E6-C8EDC0813B0CQ33650377-D8D4A7C3-472F-4D87-8C12-91F871A1E204Q33956730-166FB270-5085-40B5-9338-482E198E1632Q34085781-0B03701B-F4AD-45A7-A2BD-601388993075Q34117376-C878A23F-C23E-4C65-8162-D8B9DE6ACA08Q34224472-CA9091C4-2FE7-44D3-B152-BAFFC2D2E5F8Q34324105-C5495E8E-2632-4517-BB12-5557A9A53B91Q34339563-B6698898-0DB3-4B0C-9C47-4813527E78FCQ34372132-EC342BD2-F9E8-4D13-A9A2-622E15F25D6CQ34480551-19CE35C3-BB3A-42FA-88A4-8A29CD410552Q34496136-ED5E4DEA-26B0-4284-96CA-F1889396AF5FQ34588040-3D85F09E-177A-471B-9FED-E02BB208956DQ34956792-95D05748-7FA3-4C55-93AC-D124A4361C4DQ34990391-40F71D13-884C-486D-AC23-36F93FC89C9BQ35536515-4066FD0C-FB4F-477F-B25A-7D1C01A85D6AQ35591553-1EC8D4E4-56A7-441F-92D2-DCC9414BBF20Q35913962-53BF76CC-ECF5-40A7-9EE5-F58CED01CF58Q36388027-EB5D7AF3-B9AA-41ED-AB8A-5DAA81DD5C15Q36609344-11D4F73B-8F02-4510-B00D-42A4A669E333Q37241282-EBE34D8F-B32F-4441-90D9-FF266C1985CCQ37386831-C5EECE86-D839-45D7-8106-220CBB958A05Q37481693-B824D5C8-46FC-4AF9-8393-5EF3BC6B0FE0Q37683975-1D529988-2348-47F3-ABD1-950E362F3012Q37845433-F4DA74AC-10F5-4AD0-9F79-513DDBB817FCQ38205050-1C48CD8E-56F5-4E14-A7CB-82D8C38824DDQ38232519-930D7320-C599-430F-96BF-0715923DAD04
P50
description
Australian paediatric respiratory physician
@en
arts uit Australië
@nl
dochtúir Astrálach
@ga
dokter asal Australia
@id
médica australiana
@ast
հետազոտող
@hy
طبيبة أسترالية
@ar
name
Claire Wainwright
@ast
Claire Wainwright
@ca
Claire Wainwright
@de
Claire Wainwright
@en
Claire Wainwright
@es
Claire Wainwright
@fr
Claire Wainwright
@ga
Claire Wainwright
@nl
Claire Wainwright
@sl
Claire Wainwright
@sq
type
label
Claire Wainwright
@ast
Claire Wainwright
@ca
Claire Wainwright
@de
Claire Wainwright
@en
Claire Wainwright
@es
Claire Wainwright
@fr
Claire Wainwright
@ga
Claire Wainwright
@nl
Claire Wainwright
@sl
Claire Wainwright
@sq
altLabel
Claire E Wainwright
@nl
Claire E Wainwright
@sl
Claire E. Wainwright
@en
prefLabel
Claire Wainwright
@ast
Claire Wainwright
@ca
Claire Wainwright
@de
Claire Wainwright
@en
Claire Wainwright
@es
Claire Wainwright
@fr
Claire Wainwright
@ga
Claire Wainwright
@nl
Claire Wainwright
@sl
Claire Wainwright
@sq
P1053
G-4218-2013
P106
P1153
7006542964
P1412
P21
P27
P31
P3829
P496
0000-0001-8389-3809